Inhibikase Therapeutics (IKT) EPS (Diluted) (2021 - 2026)
Powered by 
Analysis
Inhibikase Therapeutics (IKT) EPS (Diluted) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 4.31 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 12.23 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 7.15 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -3.06 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 2.05 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1.19 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 0.15 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.06 |
| 10 | Inhibikase Therapeutics | 435.56 Mn | 276.54 Mn | - | -0.12 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.12 |
| Mar 31, 2026 | -0.10 |
| Dec 31, 2025 | -0.14 |
| Sep 30, 2025 | -0.14 |
| Jun 30, 2025 | -0.12 |
| Mar 31, 2025 | -0.16 |
| Dec 31, 2024 | -0.55 |
| Sep 30, 2024 | -0.66 |
| Jun 30, 2024 | -0.67 |
| Mar 31, 2024 | -0.75 |
| Dec 31, 2023 | -0.83 |
| Sep 30, 2023 | -0.89 |
| Jun 30, 2023 | -1.19 |
| Mar 31, 2023 | -1.03 |
| Dec 31, 2022 | -1.03 |
| Sep 30, 2022 | -1.07 |
| Jun 30, 2022 | -1.10 |
| Mar 31, 2022 | -1.10 |
| Dec 31, 2021 | -1.66 |
| Sep 30, 2021 | -1.07 |